Get started
Author

Kenzie Birse

Observed names: Birse, Kenzie, Birse, Kenzie D., K Birse, K. Birse, Kenzie D. Birse, Kenzie D. M. Birse, Kenzie M. Birse
ORCID: 0000-0002-7503-020X
Observed ORCID: 0000-0002-7503-020X
OpenAlex ID: A5021152308
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
2017 · Nichole R. Klatt, Ryan Cheu, et al. · Science · 427
PDF
Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells
2015 · Kelly B Arnold, Adam Burgener, et al. · Mucosal Immunology · 246
PDF
Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract
2016 · Alexander S. Zevin, Irene Y. Xie, et al. · PLoS Pathogens · 135
PDF
Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling
2023 · Alicia R. Berard, Douglas K. Brubaker, et al. · Cell Reports · 66
PDF
The neovaginal microbiome of transgender women post-gender reassignment surgery
2020 · Kenzie D. Birse, Kateryna Kratzer, et al. · Microbiome · 64
PDF
The vaginal microbiome amplifies sex hormone‐associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption
2018 · Frideborg Bradley, Kenzie Birse, et al. · American Journal of Reproductive Immunology · 64
Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility
2015 · Kenzie Birse, Kelly B. Arnold, et al. · Journal of Virology · 61
PDF
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
2022 · Alessandra Borgognone, Marc Noguera-Julian, et al. · Microbiome · 58
PDF
Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices
2016 · Kenzie D. Birse, Laura M. Romas, et al. · The Journal of Infectious Diseases · 53
Complement Opsonization of HIV-1 Results in Decreased Antiviral and Inflammatory Responses in Immature Dendritic Cells via CR3
2014 · Rada Ellegård, Elisa Crisci, et al. · The Journal of Immunology · 42
PDF
Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
2018 · Lauren Girard, Kenzie Birse, et al. · Scientific Reports · 33
PDF
Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition
2020 · Laura Noël-Romas, Michelle Perner, et al. · PLoS Pathogens · 31
PDF
Using safe, affordable and accessible non‐steroidal anti‐inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract
2018 · Julie Lajoie, Kenzie Birse, et al. · Journal of the International AIDS Society · 31
PDF
Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection
2013 · Kenzie M. Birse, Adam Burgener, et al. · PLoS ONE · 31
PDF
Non- Lactobacillus -Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition
2022 · Yiran Wang, Laura Noël-Romas, et al. · Clinical Infectious Diseases · 27
PDF
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data
2022 · Sean M. Hughes, Claire N. Levy, et al. · BMC Medicine · 27
PDF
Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus
2023 · Christina Farr Zuend, Alana Lamont, et al. · Microbiome · 24
PDF
Nonoptimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract
2023 · Marina Costa-Fujishima, Atta Yazdanpanah, et al. · Mucosal Immunology · 24
PDF
Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection
2020 · Sean M. Hughes, Claire N. Levy, et al. · Cell Reports Medicine · 23
PDF
Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women
2020 · Refilwe P. Molatlhegi, Lenine J. Liebenberg, et al. · Mucosal Immunology · 19
PDF
A Comparative Proteomic Analysis of the Soluble Immune Factor Environment of Rectal and Oral Mucosa
2014 · Laura M. Romas, Klara Hasselrot, et al. · PLoS ONE · 18
PDF
Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach
2015 · S. A. Vishwanathan, A. Burgener, et al. · Journal of Virology · 15
Amniotic fluid proteomic signatures of cervical insufficiency and their association with length of latency
2018 · Rachelle N. M. Govia, Kenzie D. Birse, et al. · American Journal of Reproductive Immunology · 14
Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
2020 · Christina Farr Zuend, Nicole H. Tobin, et al. · American Journal of Reproductive Immunology · 13
PDF
Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
2016 · Laura Romas, Kenzie Birse, et al. · AIDS Research and Human Retroviruses · 11
PDF
Works count: 74
Citation count: 1,633
H-index: 19
I10-index: 26
Year
Topic
Type